FDA Unveils New Pilot Program to Release Patient-Reported Symptoms from Cancer Trials
- June 26, 2020
The Food and Drug Administration launched June 23 a new pilot program that will give the public access to patient-reported data from cancer trials with the aim of better informing treatment choices.
ARTICLE TAGS
You must be logged in to access this content.